Whither M&A?

(ADAM FEUERSTEIN/STAT)

Evercore ISI analyst Josh Schimmer crunched some biotech M&A numbers and found that over the past five years, big deals tended to happen in January more than any other month. Well, JPM is about to start, it’s almost halfway through January 2020, and the biotech M&A crickets are chirping. In fact, as STAT's Adam Feuerstein noted last week, some of biotech’s buzzed-about acquisition targets have already been crossed off the “deal imminent” list.

Maybe all will be well and good tomorrow morning? If not, start to panic.